Literature DB >> 2424487

The effects of alpha M-foetoprotein, an acute phase protein, and BaSO4-induced injury on IgE-mediated, systemic anaphylaxis in the rat.

J G Ufkes, M Ottenhof, W T Labruyère, W Boers, H van Vugt, J van Gool.   

Abstract

A recently developed method for inducing fatal, IgE-mediated, bronchial and cardiovascular anaphylaxis in the rat was used to compare the effects of exogenously administered, purified alpha M-foetoprotein (alpha M FP) and BaSO4 pretreatment (as mean to induce an acute phase reaction with increased alpha M FP serum levels) with regard to mortality, bronchoconstriction and cardiovascular events. The BaSO4 pretreatment protected the rats almost completely against mortality, whereas exogenously administered alpha M FP offered no protection at all. With respect to the antigen-induced bronchoconstriction alpha M FP greatly inhibited the increase of the pulmonary resistance (RI), whereas the BaSO4 pretreatment suppressed either the dynamic lung compliance (Cdyn) or RI considerably. The cardiovascular events were only influenced by the BaSO4 pretreatment demonstrating a small but highly significant reduction of the initial fall in blood pressure together with a remarkable recovery within almost I h in the majority (91%) of the animals. Both exogenously administered alpha M FP and BaSO4 pretreatment increased the alpha M FP serum levels from a normal value of 59 +/- 4 micrograms/ml (n = 22), to 2732 +/- 252 micrograms/ml (n = 9) and 855 +/- 200 micrograms/ml (n = 22), respectively. From these data we conclude that the antianaphylactic activity of alpha M FP is limited to bronchoprotection of the more central parts of the lungs, whereas BaSO4 pretreatment covers a much broader antianaphylactic profile. This implies that BaSO4 pretreatment does not only induce alpha M FP but also other endogenous antianaphylactic factors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424487      PMCID: PMC2013025     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  8 in total

1.  Resistance of central and peripheral airways measured by a retrograde catheter.

Authors:  P T Macklem; J Mead
Journal:  J Appl Physiol       Date:  1967-03       Impact factor: 3.531

2.  Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein.

Authors:  M Costello; B A Fiedel; H Gewurz
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

3.  Inhibitory effects of rat alpha2 macroferoprotein (alphaMFP), an acute phase globulin, on galactosamine hepatitis.

Authors:  J van Gool; W Boers; I de Nie
Journal:  Exp Mol Pathol       Date:  1978-10       Impact factor: 3.362

4.  Inhibitory effects of BaSO4 on experimentally induced inflammation in the rat mediated by alpha M-foetoprotein.

Authors:  J G Ufkes; A Zeegers; W Boers; J van Gool
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-04

Review 5.  Protein synthesis during development and differentiation in the cellular slime mould Dictyostelium discoideum.

Authors:  D J Watts
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

Review 6.  Endogenous anti-inflammatory factors.

Authors:  D A Lewis
Journal:  Biochem Pharmacol       Date:  1984-06-01       Impact factor: 5.858

7.  Effect of histamine, serotonin, and acetylcholine on the peripheral airways.

Authors:  H J Colebatch; C R Olsen; J A Nadel
Journal:  J Appl Physiol       Date:  1966-01       Impact factor: 3.531

8.  The effect of prednisolone and ketotifen on the antigen-induced bronchoconstriction and mediator release in rat isolated lungs.

Authors:  M Ottenhof; J G Ufkes; H H Van Rooij
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

  8 in total
  2 in total

1.  Rat alpha 2 macroglobulin is a selective inhibitor of antigen-induced leucotrienes in rat isolated lungs.

Authors:  J G Ufkes; M Ottenhof; H H van Rooij; J van Gool
Journal:  Br J Exp Pathol       Date:  1988-08

Review 2.  Alpha-2-macroglobulin as a radioprotective agent: a review.

Authors:  Xueying Chen; Xiangbo Kong; Zhaoqiang Zhang; Wei Chen; Jieyu Chen; Huanyang Li; Wanting Cao; Yaping Ge; Silian Fang
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.